CCT
GSK icon

Chemung Canal Trust’s GSK GSK Stock Holding History

Chemung Canal Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,441
Closed -$245K – 123
2021
Q4 		$245K Hold
4,441
– – 0.04% 118
2021
Q3 		$212K Hold
4,441
– – 0.04% 120
2021
Q2 		$221K Sell
4,441
-992
-18% -$47.7K 0.04% 118
2021
Q1 		$242K Sell
5,433
-4,190
-44% -$190K 0.05% 115
2020
Q4 		$442K Sell
9,623
-36,964
-79% -$1.7M 0.09% 96
2020
Q3 		$2.19M Sell
46,587
-18,527
-28% -$928K 0.52% 65
2020
Q2 		$3.32M Sell
65,114
-67,959
-51% -$3.49M 0.87% 43
2020
Q1 		$6.3M Sell
133,073
-13,032
-9% -$695K 1.93% 15
2019
Q4 		$8.58M Sell
146,105
-2,238
-2% -$124K 1.95% 14
2019
Q3 		$7.91M Buy
148,343
+2,153
+1% +$111K 1.93% 14
2019
Q2 		$7.31M Sell
146,190
-9,811
-6% -$492K 1.7% 21
2019
Q1 		$8.15M Buy
156,001
+67,607
+76% +$3.38M 1.94% 17
2018
Q4 		$4.22M Buy
88,394
+1,796
+2% +$88.4K 1.21% 36
2018
Q3 		$4.35M Buy
86,598
+24,120
+39% +$1.23M 0.96% 38
2018
Q2 		$3.15M Buy
+62,478
New +$3.15M 0.76% 43
2017
Q3 		– Sell
-3,887
Closed -$210K – 125
2017
Q2 		$210K Buy
+3,887
New +$207K 0.05% 118
2015
Q4 		– Sell
-4,653
Closed -$223K – 132
2015
Q3 		$223K Buy
4,653
+539
+13% +$28.1K 0.05% 124
2015
Q2 		$214K Buy
4,114
+61
+2% +$3.44K 0.05% 130
2015
Q1 		$233K Buy
4,053
+292
+8% +$16.7K 0.05% 130
2014
Q4 		$200K Buy
+3,761
New +$210K 0.04% 134

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Chemung Canal Trust's GSK Position: Q1 2022 in Review

Chemung Canal Trust sold out of GSK (GSK) in Q1 2022, closing a stake of 4,441 shares — an estimated $245K sold.

Chemung Canal Trust first reported a position in GSK in Q4 2014 and held it in 20 quarters. The position peaked at $8.58M in Q4 2019. 930 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

  • Chemung Canal Trust reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
  • Chemung Canal Trust sold 4,441 GSK shares in Q1 2022, an estimated $245K.
  • Chemung Canal Trust first reported a position in GSK in Q4 2014 and held it in 20 quarters.
  • Chemung Canal Trust's GSK position peaked at $8.58M in Q4 2019.
  • 930 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on Chemung Canal Trust's 13F filing for Q1 2022, filed 14 Apr 2022.